Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis

被引:51
作者
Chen, Cong [1 ,2 ,3 ]
Xie, Bojian [1 ,2 ,3 ,4 ]
Li, Zhaoqing [1 ,2 ,3 ]
Chen, Lini [1 ,2 ,3 ]
Chen, Yongxia [1 ,2 ,3 ]
Zhou, Jichun [1 ,2 ,3 ]
Ju, Siwei [1 ,2 ,3 ]
Zhou, Yulu [1 ,2 ,3 ]
Zhang, Xun [1 ,2 ,3 ]
Zhuo, Wenying [1 ,2 ,3 ]
Yang, Jingjing [1 ,2 ,3 ]
Mao, Misha [1 ,2 ,3 ]
Xu, Ling [1 ,2 ,3 ]
Wang, Linbo [1 ,2 ,3 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Surg Oncol, Hangzhou, Peoples R China
[2] Biomed Res Ctr, Hangzhou, Peoples R China
[3] Key Lab Biotherapy Zhejiang Prov, Hangzhou, Peoples R China
[4] Wenzhou Med Univ, Taizhou Hosp, Dept Surg Oncol, Taizhou, Peoples R China
基金
中国国家自然科学基金;
关键词
EXPRESSION; RESISTANCE; CARCINOMA; CELLS;
D O I
10.1038/s41419-022-04579-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ferroptosis, which is characterized by intracellular iron accumulation and lipid peroxidation, is a newly described form of regulated cell death that may play a key role in tumour suppression. In the present study, we investigated the expression profiles and biological effects of fascin actin-bundling protein 1 (Fascin, gene name FSCN1) in breast cancer. In addition, bioinformatics analysis of the TCGA cancer database and gain- and loss-of-function studies showed that Fascin enhances sensitivity to erastin-induced ferroptosis. Mechanistically, Fascin directly interacts with cysteine/glutamate transporter (xCT, gene name SLC7A11) and decreases its stability via the ubiquitin-mediated proteasome degradation pathway. Furthermore, we observed that Fascin is substantially upregulated in tamoxifen-resistant breast cancer cell lines, and drug-resistant cells were also more vulnerable to erastin-induced ferroptosis. Taken together, our findings reveal a previously unidentified role of Fascin in ferroptosis by regulating xCT. Thus, ferroptosis activation in breast cancer with high Fascin level may serve as a potential treatment.
引用
收藏
页数:14
相关论文
共 40 条
[31]   LinkedOmics: analyzing multi-omics data within and across 32 cancer types [J].
Vasaikar, Suhas V. ;
Straub, Peter ;
Wang, Jing ;
Zhang, Bing .
NUCLEIC ACIDS RESEARCH, 2018, 46 (D1) :D956-D963
[32]   Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway [J].
Viswanathan, Vasanthi S. ;
Ryan, Matthew J. ;
Dhruv, Harshil D. ;
Gill, Shubhroz ;
Eichhoff, Ossia M. ;
Seashore-Ludlow, Brinton ;
Kaffenberger, Samuel D. ;
Eaton, John K. ;
Shimada, Kenichi ;
Aguirre, Andrew J. ;
Viswanathan, Srinivas R. ;
Chattopadhyay, Shrikanta ;
Tamayo, Pablo ;
Yang, Wan Seok ;
Rees, Matthew G. ;
Chen, Sixun ;
Boskovic, Zarko V. ;
Javaid, Sarah ;
Huang, Cherrie ;
Wu, Xiaoyun ;
Tseng, Yuen-Yi ;
Roider, Elisabeth M. ;
Gao, Dong ;
Cleary, James M. ;
Wolpin, Brian M. ;
Mesirov, Jill P. ;
Haber, Daniel A. ;
Engelman, Jeffrey A. ;
Boehm, Jesse S. ;
Kotz, Joanne D. ;
Hon, Cindy S. ;
Chen, Yu ;
Hahn, William C. ;
Levesque, Mitchell P. ;
Doench, John G. ;
Berens, Michael E. ;
Shamji, Alykhan F. ;
Clemons, Paul A. ;
Stockwell, Brent R. ;
Schreiber, Stuart L. .
NATURE, 2017, 547 (7664) :453-+
[33]   Fascin-1 as a novel diagnostic marker of triple-negative breast cancer [J].
Wang, Chao-Qun ;
Tang, Chih-Hsin ;
Chang, Hao-Teng ;
Li, Xiao-Ni ;
Zhao, Yong-Ming ;
Su, Chen-Ming ;
Hu, Gui-Nv ;
Zhang, Tao ;
Sun, Xin-Xin ;
Zeng, Yue ;
Du, Zhang ;
Wang, Yan ;
Huang, Bi-Fei .
CANCER MEDICINE, 2016, 5 (08) :1983-1988
[34]   The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy [J].
Wang, Ji ;
Xie, Shuduo ;
Yang, Jingjing ;
Xiong, Hanchu ;
Jia, Yunlu ;
Zhou, Yulu ;
Chen, Yongxia ;
Ying, Xiaogang ;
Chen, Cong ;
Ye, Chenyang ;
Wang, Linbo ;
Zhou, Jichun .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
[35]   Fascin1 expression predicts poor prognosis in patients with nasopharyngeal carcinoma and correlates with tumor invasion [J].
Wu, D. ;
Chen, L. ;
Liao, W. ;
Ding, Y. ;
Zhang, Q. ;
Li, Z. ;
Liu, L. .
ANNALS OF ONCOLOGY, 2010, 21 (03) :589-596
[36]   MicroRNA-488 inhibits proliferation and motility of tumor cells via downregulating FSCN1, modulated by Notch3 in breast carcinomas [J].
Wu, Yang ;
Yuan, Ming-Heng ;
Wu, Hua-Tao ;
Chen, Wen-Jia ;
Zhang, Man-Li ;
Ye, Qian-Qian ;
Liu, Jing ;
Zhang, Guo-Jun .
CELL DEATH & DISEASE, 2020, 11 (10)
[37]   Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion [J].
Wu, Zheng-sheng ;
Wang, Chao-qun ;
Xiang, Ru ;
Liu, Xue ;
Ye, Shan ;
Yang, Xue-qing ;
Zhang, Gui-hong ;
Xu, Xiao-chun ;
Zhu, Tao ;
Wu, Qiang .
BMC CANCER, 2012, 12
[38]   CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer [J].
Zhang, Haiyang ;
Deng, Ting ;
Liu, Rui ;
Ning, Tao ;
Yang, Haiou ;
Liu, Dongying ;
Zhang, Qiumo ;
Lin, Dan ;
Ge, Shaohua ;
Bai, Ming ;
Wang, Xinyi ;
Zhang, Le ;
Li, Hongli ;
Yang, Yuchong ;
Ji, Zhi ;
Wang, Hailong ;
Ying, Guoguang ;
Ba, Yi .
MOLECULAR CANCER, 2020, 19 (01)
[39]  
Zhao H, 2016, AM J TRANSL RES, V8, P3106
[40]   The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer? [J].
Zhou, Yulu ;
Shen, Yong ;
Chen, Cong ;
Sui, Xinbing ;
Yang, Jingjing ;
Wang, Linbo ;
Zhou, Jichun .
CANCER BIOLOGY & MEDICINE, 2019, 16 (04) :630-646